…
The Schiehallion Fund Limited specializes in growth capital and later stage investments. The fund seeks to invest in private businesses which have the potential of trading on a public stock exchange. The fund doesn't have any specific industry or geographic sector focus. The fund typically invests in the form of equity and equity-related instruments (which may include, without limitation, preference shares, convertible debt instruments, equity-related and equity-linked notes and warrants) issued by portfolio companies. The fund doesn't make initial investment which exceeds the 10 percent of most recent net asset value of the portfolio company. The fund also doesn't seek to make investments in excess of 19.9 or 20 percent of the value of portfolio companies. It invests in the companies having enterprise value of at least $500 million. The fund seeks to make long term minority investments.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 |
| Income before tax | 154.55M | 68.64M | -319.33M | 30.27M | 208.30M |
| Net income | 155.07M | 67.81M | -319.33M | 30.27M | 208.30M |
| Selling general administrative | 1.89M | 9.41M | 1.23M | 1.10M | 0.76M |
| Selling and marketing expenses | 0.06M | - | - | - | - |
| Gross profit | 156.50M | 77.98M | -318.10M | 31.37M | 209.06M |
| Ebit | 309.08M | 137.20M | - | 30.30M | 208.30M |
| Ebitda | 154.55M | 68.64M | -319.33M | 30.28M | 208.30M |
| Depreciation and amortization | -154.53M | -68.56M | - | - | - |
| Operating income | 154.55M | 68.64M | -319.33M | 30.28M | 208.30M |
| Other operating expenses | 1.96M | 9.34M | 1.23M | 1.10M | 0.76M |
| Interest expense | - | 0.00M | 0.01M | 0.01M | 0.00M |
| Tax provision | -0.52M | 0.83M | 0.00M | 0.01M | 0.00M |
| Interest income | 7.51M | 8.21M | 2.80M | 0.36M | 2.76M |
| Net interest income | 7.51M | 8.21M | 2.79M | 0.36M | 2.76M |
| Income tax expense | -0.52M | 0.83M | - | - | - |
| Total revenue | 156.50M | 77.98M | -318.10M | 31.37M | 209.06M |
| Total operating expenses | 1.96M | 9.34M | 1.23M | 1.10M | 0.76M |
| Cost of revenue | - | 8.08M | - | - | 3.60M |
| Total other income expense net | - | 0.07M | -0.01M | -0.01M | - |
| Net income from continuing ops | 155.07M | 67.81M | -319.33M | 30.27M | 208.30M |
| Net income applicable to common shares | - | - | - | 30.27M | 208.30M |
| Breakdown | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 |
| Total assets | 1375.33M | 1224.35M | 1155.51M | 1503.84M | 707.72M |
| Other current assets | -1.43M | 0.13M | - | - | 0.25M |
| Total liab | 5.37M | 5.21M | 2.33M | 31.33M | 1.64M |
| Total stockholder equity | 1369.96M | 1219.14M | 1153.18M | 1472.51M | 706.08M |
| Other current liab | 3.15M | 0.31M | -2.33M | -31.33M | -1.64M |
| Common stock | 1209.21M | 1213.90M | 1216.50M | 1216.50M | 480.34M |
| Capital stock | 1209.21M | 1213.90M | 1216.50M | 1216.50M | 480.34M |
| Retained earnings | -17.00M | -16.55M | - | 251.36M | 225.73M |
| Other assets | 1375.33M | - | - | 1503.84M | 707.72M |
| Cash | 6.12M | 11.31M | 45.80M | 86.90M | 16.11M |
| Total current liabilities | 5.05M | 2.12M | 2.33M | 31.33M | 1.64M |
| Net debt | -6.12M | -11.31M | -45.80M | -86.90M | -16.11M |
| Other stockholder equity | 7.30M | 5.23M | -63.32M | 256.01M | 225.74M |
| Total current assets | 6.12M | 13.05M | 46.68M | 87.30M | 16.54M |
| Long term investments | 1367.78M | 1211.30M | 1108.83M | 1416.54M | 691.18M |
| Net tangible assets | - | - | - | 1472.51M | 706.08M |
| Short term investments | - | - | - | - | 77.00M |
| Net receivables | 1.43M | 1.62M | 0.88M | 0.41M | 0.43M |
| Inventory | - | -0.13M | - | - | - |
| Accounts payable | 1.91M | 1.81M | 2.33M | 31.33M | 1.64M |
| Accumulated other comprehensive income | 177.75M | 21.79M | - | - | - |
| Non currrent assets other | 1.43M | -1211.30M | -1108.83M | -1416.54M | -691.18M |
| Non current assets total | 1369.21M | 1211.30M | 1108.83M | 1416.54M | 691.18M |
| Breakdown | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 |
| Investments | 8.74M | -27.40M | -31.19M | -657.15M | 4.80M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | 8.74M | -27.40M | - | -657.15M | 4.80M |
| Total cash from financing activities | -4.14M | -1.85M | 736.41M | 736.41M | 4.45M |
| Net income | 154.55M | 68.64M | -319.33M | 30.27M | 208.30M |
| Change in cash | -5.19M | -34.49M | -41.10M | 70.78M | 5.98M |
| Begin period cash flow | 11.31M | 45.80M | 86.90M | 16.11M | 10.13M |
| End period cash flow | 6.12M | 11.31M | 45.80M | 86.90M | 16.11M |
| Total cash from operating activities | -9.80M | -5.32M | -9.89M | -8.46M | -3.27M |
| Issuance of capital stock | - | - | 0.00M | 736.41M | 4.45M |
| Other cashflows from investing activities | - | - | - | 0.10M | 0.10M |
| Change to account receivables | 0.91M | 1.19M | - | 0.88M | 1.23M |
| Sale purchase of stock | -4.14M | -1.85M | - | - | 4.45M |
| Other cashflows from financing activities | - | -27.40M | -31.19M | -657.15M | 4.80M |
| Change to netincome | - | - | - | -39.61M | -212.80M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 0.91M | 1.19M | -0.90M | 0.88M | 1.23M |
| Other non cash items | -165.26M | -75.15M | 310.34M | -39.61M | -212.80M |
| Free cash flow | -9.80M | -5.32M | -9.89M | -8.46M | -3.27M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| MNTN Schiehallion Fund Ltd |
-0.01 0.46% |
2.18 | 0.05 | - | 4.35 | 1.25 | 5.65 |
| BHMU BH Macro Limited |
- -% |
4.29 | 0.09 | - | 39.01 | 0.71 | 6.47 |
| TFG Tetragon Financial Group Ltd |
0.15 1.00% |
15.10 | 0.02 | 7.04 | 1.16 | 0.31 | 2.06 |
| BPCR BioPharma Credit PLC |
0.00 0.41% |
0.98 | 0.09 | - | 6.73 | 0.91 | 7.95 |
| RTW RTW Venture Fund Ltd |
0.06 2.58% |
2.39 | 0.03 | - | 19.21 | 0.76 | 2.61 |
The Schiehallion Fund Limited specializes in growth capital and later stage investments. The fund seeks to invest in private businesses which have the potential of trading on a public stock exchange. The fund doesn't have any specific industry or geographic sector focus. The fund typically invests in the form of equity and equity-related instruments (which may include, without limitation, preference shares, convertible debt instruments, equity-related and equity-linked notes and warrants) issued by portfolio companies. The fund doesn't make initial investment which exceeds the 10 percent of most recent net asset value of the portfolio company. The fund also doesn't seek to make investments in excess of 19.9 or 20 percent of the value of portfolio companies. It invests in the companies having enterprise value of at least $500 million. The fund seeks to make long term minority investments.
Calton Square, Edinburgh, United Kingdom, EH1 3AN
44 131 275 2000
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter Singlehurst | Mang. | NA |
| Dr. Mark Andrew Urquhart Ph.D. | Deputy Mang. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.